Skip to main content
. 2022 Oct 27;24(10):e40877. doi: 10.2196/40877

Table 2.

List of barriers to and facilitators of the implementation of telemedicine across the 53 member states of the World Health Organization European Region and the main methodological limitations of the included studies.

Domain Barriers Facilitators
Individual domain
  • Shortcomings in technology-related knowledge and skill [21,24,41,45,51]

  • Resistance to change [40,42,49,51]

  • Patients’ age [24,40,41,45]

  • Lack of motivation or support [36,45,51]

  • Lack of confidence [49,51]

  • Challenges for individuals with disabilities [26,51]

  • Patients’ preference for face-to-face consultations [40,41,51]

  • Low satisfaction [21,51]

  • Language barriers [41,51]

  • Lack of acceptance [52]

  • Lack of usefulness [41]

  • Less personal contact through telemedicine [39]

  • Invasiveness [39]

  • High attrition rate [35]

  • Patient empowerment [31,35,51]

  • Participatory design [33,35,41,42]

  • Motivation and engagement [31,36,42,51]

  • Convenience [40,51,53]

  • Patients’ age [24,41,45]

  • Trust in technology [35,45]

  • Patients feel safe and empowered to discuss personal issues [51]

  • Physicians’ training and skills [31,45]

  • Satisfaction [36,51]

  • Adoption of digital culture [52]

  • Patients sharing their experiences [45]

Organizational domain
  • The lack of integration into clinicians’ workflows [31,42,44,51]

  • Socioeconomic aspects (financial limitations) [24,25,31,40]

  • Lack of access to a helpful caregiver [26,39,45]

  • Sociocultural aspects [21,40]

  • Increase in workload [51]

  • Scheduling conflicts [31]

  • Lack of governance [52]

  • No appropriate Health Information Systems framework [49]

  • Organizational issues creating barriers to long-term implementation [26]

  • Reduction in response time [40,51,53]

  • Integration into clinicians’ workflows [31,42]

  • Decrease in workload [37,51]

  • Access to a helpful caregiver and insights into patient’s home environment [45,51]

  • Pandemic- created acceptance of technology [51]

  • Increased adherence [51]

  • Coordination between healthcare levels [52]

  • Telemedicine champions [34]

Clinical domain
  • Limited scientific evidence [29,30,32,33,35]

  • Patient recruitment barriers and low rates of patient participation [28,46]

  • Difficulty in making clinical decisions [49,51]

  • Changes to consultation protocols [51]

  • Insufficient consultation time [51]

  • Loss of physical and visual assessment of symptoms [51]

  • Clinical and professional benefits [33,34,51]

  • Assessment after a specified period with service evaluations, including feedback from key stakeholders [33,42]

  • Multidisciplinary care team interventions [33]

  • The establishment of guidelines [49]

  • Reduction in the number of visits [36]

  • Frequent and multimodal communication between the health care professional and patient [38]

  • Greater safety and efficacy [42]

  • Better monitoring of cases [51]

Economic domain
  • Elevated cost of implementation [23,27,45]

  • Lack of funding model [34,42,43,51]

  • Scarce economic benefits [21]

  • Financial framework [49,51]

  • Financial benefits [34,45]

  • Cost savings [36]

Technological domain
  • Issues with internet access [24,26,31,35]

  • Technology needs further development [23,37,45]

  • Usability factors [25,31,41]

  • Issues with information technology and systems infrastructure [25,42]

  • Concerns about the reliability of the technology [21,41,45]

  • Issues surrounding infrastructure [44]

  • Conflicts of interoperability [52]

  • Difficulties in implementation and follow-up over a longer period [27]

  • Difficulties in readability [25]

  • Limited accessibility to electronic devices [24]

  • Usability and user satisfaction factors [31,33,45]

  • Internet availability [31,35]

  • Possibilities of technology development [52]

  • Accessibility support [31,35]

  • Adaptable and self-configurable [52]

Ethics, security, and privacy issues
  • Private data security concerns or issues [38,45,51]

  • Regulatory concerns or issues [21,44,49]

  • Concerns about patient and staff safety [21,41]

  • Ethical aspects [21]

  • Legal framework [49]